| Ticker |
BMY
|
| CIK | 0000014272 |
| SIC | 2834 |
| Sector | Manufacturing |
| Industry Category | Pharmaceutical Products |
| Industry Group | Pharmaceutical Preparations |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Winn CIPP Welcomes Cohort 4 Medical Students Focused on Connecting Communities to Clinical ResearchOriginally published by The Robert A. Winn Excellence In Clinical Trials Award Program NORTHAMPTON, MA / ACCESS Newswire / July 14, 2025 / The Robert A. Winn Clinical Investigator Pathway Program (Winn CIPP), a national program out of VCU Massey Comprehensive ... Invenra Welcomes Dr. Alan J. Korman to Its Scientific Advisory BoardMADISON, Wis., July 14, 2025--Invenra, a biotechnology company specializing in next-generation multispecific antibody discovery and development, is pleased to announce the appointment of Dr. Alan J. Korman, PhD, FAIO, to its Scientific Advisory Board (SAB). Dr. Korman brings a wealth of experience in immuno-oncology, having played a pivotal role in the development of groundbreaking cancer immunotherapies. 3 Top Dividend Stocks to Maximize Your Retirement IncomeThe traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields. Should SPDR Russell 1000 Low Volatility Focus ETF (ONEV) Be on Your Investing Radar?Style Box ETF report for ONEV Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar?Style Box ETF report for FVD |
